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Abstract
Maternal thyroid hormones facilitate optimal foetal neurodevelopment; however, the exact role of the thyroid hormones on specific cognitive outcomes is
unknown. The present study aimed to investigate associations between maternal thyroid function and neurodevelopmental outcomes in the Seychelles Child
Development Study (SCDS) Nutrition 2 cohort (n 1328). Maternal free thyroid hormones (fT3, fT4 and fTSH) were assessed at 28 weeks’ gestation with a
range of child cognitive outcomes analysed at 20 months. Dietary iodine intake was analysed for a subset of women through a Food Frequency
Questionnaire. Linear regression analysis was used to test associations between serum concentrations of maternal thyroid hormones and child neurode-
velopment outcomes. Thyroid hormones were analysed as continuous data and categorised as quintiles. 95 % of mothers had optimal thyroid function
based on fTSH concentrations. Overall, the present study shows that maternal thyroid function is not associated with neurodevelopmental outcomes
in this high fish-eating population. However, a positive association, using quintiles for fT3, was reported for the Mental Developmental Index, between
Q3 v. Q4 (β 0⋅073; P 0⋅043) and for Q3 v. Q5 (β value 0⋅086; P 0⋅018). To conclude, mothers in our cohort, who largely have optimal thyroid function and
iodine intakes, appear able to regulate thyroid function throughout pregnancy to meet neurodevelopmental needs. However, it is possible that minor imbal-
ances of fT3, as indicated from our secondary analysis, may impact offspring neurodevelopment. Further investigation of the relationship between maternal
thyroid function and infant neurodevelopment is warranted, particularly in populations with different dietary patterns and thereby iodine intakes.
Key words: Cognitive development: Iodine: Thyroid function
Introduction
Iodine is an essential micronutrient required for the produc-
tion of the thyroid hormones, triiodothyronine (T3) and
thyroxine (T4), which are necessary throughout pregnancy
for adequate foetal neurodevelopment(1). During pregnancy,
the maternal thyroid is stimulated by elevated thyroxine-
Abbreviations: FFQ: Food Frequency Questionnaire; fT3: free triiodothyronine; fT4: free thyroxine; MDI: Mental Developmental Index; PDI: Psychomotor Developmental
Index; TSH: thyroid-stimulating hormone
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binding globulin to produce more thyroid hormones as a result
of foetal and placental demand(2,3). Demand is further exacer-
bated by the immaturity of the foetal thyroid gland and although
this changes during mid-gestation, dependency upon maternal
iodine stores remains owing to the rapid transfer of iodide
across the placenta in tandem with the high foetal thyroidal
turnover(1,4–6). As pregnancy progresses, mothers experience
enhanced renal iodine clearance and glomerular filtration rate,
making the maintenance of adequate foetal and maternal iodine
status more complex(3). The World Health Organization
(WHO) recommends an increased requirement for iodine
of 250 μg/d during pregnancy, which differs from the
150 μg/d recommended for the general population(5).
Clinically, iodine deficiency during pregnancy is defined as urin-
ary iodine concentrations (UIC) of <150 μg/l(5).
Thyroid hormones play a crucial role in foetal neurodeve-
lopment. During the second half of the first trimester,
an adequate maternal supply of T4 is required to initiate neur-
onal proliferation and migration in the cerebral cortex(7).
Throughout the second trimester, there is a surge in maternal
thyroid hormones alongside a decline in thyroid-stimulating
hormone (TSH) that facilitates both growth and neurodeve-
lopmental mechanisms in the developing foetus(8). Post-natal
neurodevelopment including further neuronal proliferation is
reliant upon adequate amounts of maternal thyroid hormones
transferred throughout each trimester(9).
During early pregnancy, maternal fT4 is the sole source of
thyroid hormones, with various studies reporting early preg-
nancy as a critical window for foetal neurodevelopment with
lower intelligence scores determined in later testing of the off-
spring(1,10–14). Studies focused on this period of early gestation
(<20 weeks) have also reported that suboptimal early pregnancy
thyroid hormone concentrations may be associated with expres-
sive language delay, congenital malformations and increased
likelihood of problematic behaviour throughout childhood(13).
Extensive research into the role of iodine in both growth
and neurodevelopment has confirmed that severe deficiency
throughout pregnancy is clinically manifested as cretinism
amongst children (e.g. stunted growth and abnormal cognitive
functioning)(15). However, there is also evidence from several
countries to suggest negative implications of mild maternal iod-
ine deficiency during pregnancy. Indeed, the Avon Longitudinal
Study of Parents and Children (ALSPAC) in the UK found
that suboptimal iodine intake resulted in poor cognitive out-
comes relating to verbal IQ, reading accuracy and reading
comprehension; these poor outcomes were observed amongst
the assessed cohort having a median UIC of 91⋅1 μg/l (IQR
53⋅8–143 μg/l)(16). Furthermore, the Norwegian Mother and
Child Cohort Study (MoBa), correlated decreased iodine
intakes throughout pregnancy (defined as the mildly deficient
range of ∼120 μg/d) to child language delay, increased behav-
iour problems and reduced fine motor skills(17).
The effect of excess iodine on thyroid function is classified
as the Wolff Chaikoff effect, a protective mechanism in place
to protect against the overproduction of thyroid hormones, as
excess iodine results in an inhibitory action on T4 synthesis(18).
Adults are typically able to overcome the effect and thereby
protect against the development of hypothyroidism, but the
immature neonatal gland cannot(18). As such the foetus is
more susceptible to hypothyroidism and thereby longer-term
consequences on thyroid function(18).
A paper published, in 2018, found that dietary iodine intakes
at both ends of the spectrum throughout pregnancy were asso-
ciated with poorer childhood neurodevelopment outcomes at
the 18-month stage; intakes of <220 μg/d as well as >391
μg/d resulted in lower cognitive, language and motor scores(19).
Indeed, several studies support this work and the importance of
optimal thyroid hormone status throughout pregnancy particu-
larly that of T4, in relation to cognitive development, and have
concluded that there is an optimum range of concentrations
required(20–22). These findings should be viewed with caution
but suggest that a delicate balance regarding thyroid function
and hormone concentrations is required throughout gesta-
tion(22). The intake of iodine during pregnancy, however,
required to maintain TSH and T4 concentrations for optimal
neurodevelopment remains unknown.
The Seychellois population consume fish frequently in their
diet averaging up to nine portions a week and fish is one of the
richest sources of iodine in the diet(23,24). Additionally, as part
of global efforts to eliminate iodine deficiency disorders, the
Seychellois Government has adopted the Universal Salt
Iodisation (USI) programme, whereby iodised salt is added
both at the manufacturing stage and for home use in ppm
(parts per million)(25). Subsequently, it has been assumed
that the Seychellois population possess sufficient and poten-
tially even excess iodine intakes(26).
The aim of the present study is to investigate associations
between maternal thyroid function and neurodevelopmental out-
comes at 20 months of age in a high fish consuming population.
We measured thyroid hormones in Seychellois women at 28
weeks’ gestation during their third trimester and administered
a test battery to the children at 20 months of age.
Subjects and methods
Study population
The Seychelles Child Development Study is centred in the
Seychelles, a group of islands off the coast of Africa and has
been described previously elsewhere(27). The present study
was conducted according to the guidelines laid down in the
Declaration of Helsinki. Ethical approval for all procedures
involving human participants was obtained from the
Seychelles Ethics Board and the Research Subject Review
Board at the University of Rochester. Written informed con-
sent was obtained from all participants. The recruitment pro-
cess of the NC2 cohort is detailed in Fig. 1(27).
Analytical procedures
For the evaluation of thyroid function, concentrations of the
‘free’ thyroid hormones, denoted as fTSH, fT3 and fT4,
were measured. Non-fasting maternal blood samples (30 ml)
were taken at 28 weeks’ gestation. The samples were processed
immediately (collection by antecubital venepuncture into evac-























































































































30 min prior to being centrifuged at 2500 rpm for 15 min)
with the aliquots stored at −80°C until analysis. Serum ali-
quots were shipped to Ulster University before undergoing
analysis at the Institute of Clinical Chemistry and Laboratory
Medicine (IKCL) at the University Medicine Greifswald,
Germany. From serum samples, TSH, free triiodothyronine
(fT3) and free thyroxine (fT4) were analysed on the
Dimension Vista® 1500 System (Siemens Healthcare
Diagnostics, Eschborn, Germany). All analyses were per-
formed as single measurements. TSH, fT3 and fT4 were ana-
lysed using Siemens chemiluminescent immunoassay assays
based on LOCI® technology (REF K6412, K6416, K6410).
Concentrations of fT4 are considered the best determinant
of thyroid function, but pregnancy-specific reference ranges
have yet to be established. Presently, maternal TSH within
the reference range of 0⋅3–3⋅0 mIU/l is referred to as optimal
TSH based on recommendations by the American Thyroid
Association (ATA)(28). Values outside of this range are referred
to as suboptimal.
Test battery
Tests for the children included the Bayley Scales of Infant
Development (BSID-II) that yields a Mental Developmental
Index (MDI) and a Psychomotor Developmental Index
(PDI); The McArthur-Bates Communicative Development
Inventory (CDI) that yields scores for total gestures, vocabu-
lary understood and vocabulary produced; and the Infant
Behaviour Questionnaire (IBQ-R) that gives scores for nega-
tive affect, effortful control and surgency (a personality factor
characterised by quickness and cleverness). These three tests
assess a range of verbal and non-verbal developments of the
offspring including language, communication and social inter-
action(29–33).
The MDI assesses cognition through the evaluation of sen-
sory perception, knowledge, memory, problem solving and early
language. The PDI assesses the psychomotor development of
offspring and is viewed in tandem with the MDI as a means of
detailing children’s overall cognitive development(29). The
MacArthur-Bates Communicative Development Inventory
(CDI) measures expressive and receptive language func-
tions(30,31). The IBQ measures behavioural development(34).
Maternal and Child Health nurses with special training in
assessing child development administered the test battery to
offspring and their parents at approximately 20 months of age.
Iodine intake
Nutritionists at Ulster University designed a Food Frequency
Questionnaire (FFQ) specifically for use in the Seychelles. At























































































































28 weeks’ gestation, specially trained registered nurses admi-
nistered this FFQ to a subset of pregnant women (n 422)
to assess dietary intakes(33). The questionnaire asked partici-
pants to specify their average consumption of foods, including
various fish species, over the previous 6 months. It included a
total of 137 questions on a range of food items. Completed data
from the FFQs were entered into QBuilder software (Tinuviel,
version 4.0, Anglesey, UK) to estimate iodine intakes (μg/d) and
was adapted to incorporate specific Seychellois food items using
the Seychellois food composition database.
Statistics
Maternal and child characteristics were examined, and all data
were treated as continuous except for child sex. Based on the
Kolmogorov–Smirnov and Shapiro–Wilk tests, the data did not
have a normal distribution and so were log-transformed prior
to analysis. The removal of two participants with extreme values
for both fT3 and fT4 resulted in n 1328 mothers for inclusion.
Multiple linear regression models were used to examine the
associations between maternal fT4, fT3 and fTSH concentra-
tions and the children’s neurodevelopmental tests, first as con-
tinuous data. In addition, secondary linear regression models
were used to assess non-linear relationships, as evidence sug-
gests that extremes of thyroid hormones may impact cognitive
scores(20). Concentrations of fT3, fT4 and fTSH were cate-
gorised into quintiles to test their relationships with cognitive
data. Quintile 3 was used as the normal reference value for
all thyroid hormones (Table 1).
Given the proportion of our cohort who completed the
FFQ (n 422; 32 %) and the limitations of dietary data, we
chose to use the iodine intake data estimated from the FFQ
for descriptive purposes only (Table 2).
Covariates
All models were adjusted for covariates measured within the
present study which are known to be associated with child
neurodevelopmental outcomes. These were selected a priori
as in previous analyses of this cohort. Covariates included
maternal age at enrolment; maternal BMI at 20 months; gesta-
tional age; child sex, child age at testing and, as reported by
mothers during pregnancy using questionnaires, maternal IQ
using K-BIT; and family status and Hollingshead SES(24).
Statistical analysis was conducted using Statistical Package
for Social Sciences (SPSS, version 25, IBM, Chicago, IL,
USA). Taking into consideration the covariates outlined, the
total number of women included in the adjusted analyses
was n 1328. The level for determining statistical significance
for the two-tailed tests was set at P < 0⋅05.
Results
Table 2 presents a summary of data for participant character-
istics. The median age of mothers included was 25⋅91 years
with the median gestational age of 39 weeks; a total of 111 pre-
mature births (<36 weeks) were recorded. Neurodevelopmental
testing was conducted on children between 15 and 32 months
(median of 20 months). Women included in the study had a
median BMI of 26⋅14 kg/m2, classifying them in the slightly
overweight category. For the subset of mothers who completed
the FFQ (n 422), their median iodine intake was 233 μg/d,
slightly below the recommended iodine intake for pregnancy
as advised by the WHO (>250 μg/d)(5). Based on available
TSH measurements within our cohort (n 1328), 95 % (n
1259) had concentrations within the range of 0⋅3 and 3⋅0
mIU/l, referred to as optimal thyroid function(28). A total of
70 women (5 %) had TSH concentrations either above or
below this range, classifying them as having suboptimal (<0⋅3
mIU/l) or supraoptimal (>3⋅0 mIU/l) thyroid hormone status.
The T4 concentrations of these seventy women were also ana-
lysed with respect to the current reference range during preg-
nancy of 9⋅0–25⋅0 μmol/l(28). Only one individual displayed
suboptimal T4 and TSH concentrations, potentially indicative
of a more serious thyroidal condition. For this analysis, all
women were included irrespective of whether their TSH was
classified as suboptimal or supraoptimal.
As shown in Table 3, there were no significant associations
overall between maternal concentrations of fT3, fT4 or fTSH
and child neurodevelopmental outcomes, when adjusting for
the selected covariates as outlined.
Results of analyses examining relationships with quintiles of
each thyroid hormone (fT4, fT3 and fTSH) are shown in
Tables 4–6. Table 4 depicts fT4, with no associations found
in this model. As shown in Table 5, our results indicate that
for both Q4 and Q5 of fT3, there is a positive significant asso-
ciation with MDI, compared to the middle quintile (reference)
Q3, for Q4 (β 0⋅073; P 0⋅043) and for Q5 (β 0⋅086; P 0⋅018).
This difference suggests that higher concentrations of fT3
when compared to the reference quintile and thereby lower
concentrations were associated with improved scores on the
MDI. Table 6 illustrates fTSH, which like fT4 showed no asso-
ciation in this model. These results are illustrated by box plots
in Fig. 2.
Discussion
We found no association between maternal thyroid function
during pregnancy and children’s neurodevelopmental out-
comes at 20 months in the Seychelles Child Development
Study (SCDS). In this cohort, mothers largely had optimal iod-
ine intakes and thyroid function and only a small number were
above or below the reference range. In the Seychelles, mothers
appear to regulate thyroid function throughout pregnancy in
Table 1. Quintile concentrations of maternal thyroid hormones (fT4, fT3
and fTSH) measured in the SCDS NC2 (n 1328)
Quintile fT4 (μmol/l) fTSH (mIU/l) fT3 (μmol/l)
Q1 <10⋅30 (n 246) <0⋅82 (n 264) <3⋅32 (n 262)
Q2 10⋅30–11⋅19(n 268) 0⋅82–1⋅09 (n 277) 3⋅32–3⋅58 (n 269)
Q3 (Ref) 11⋅20–12⋅09 (n 277) 1⋅09–1⋅39 (n 262) 3⋅59–3⋅84 (n 259)
Q4 12⋅10–13⋅00 (n 277) 1⋅40–1⋅80 (n 266) 3⋅85–4⋅40 (n 269)
Q5 >13⋅00 (n 260) >1⋅80 (n 259) >4⋅41(n 269)
fTSH, free thyroid-stimulating hormone; mIU/l, milliunits per litre; fT4, free thyroxine;























































































































order to meet the neurodevelopmental needs of their children.
However, we did detect some positive associations with neu-
rodevelopmental outcomes. When fT3 was assessed categoric-
ally using quintiles, the higher quintile measurements of fT3
(Q4 and Q5) compared to the middle quintile showed
improvement in the BSID MDI.
The Seychellois population are proposed to have adequate
exposure to dietary iodine through both their high fish con-
sumption, the implementation of iodised salt, and salt used
both in the home and within the food industry (i.e. processed
items such as bread), with this confirmed by our estimated
intake of 233 μg/d(25). Despite this high intake, there was no
adverse association with neurodevelopment, an important
finding, given the adverse effect of high iodine intakes on thy-
roid function and thereby offspring neurodevelopment previ-
ously reported(19). Nevertheless, in countries with lower fish
intake and lack of iodised salt programmes, this may not be
the same. As such it remains important for future work to
be conducted amongst populations with varying intakes of
iodine-rich foods to further investigate the associations
between thyroid function and neurodevelopment(16,17).
The importance of adequate maternal thyroid hormone con-
centrations in relation to optimal cognitive functioning has
previously been conducted as part of the SCDS testing.
Davidson et al. conducted analysis on the NC1 cohort (n
300) and found a significant association between maternal
TSH concentrations and scores on the Percentage
Anticipatory Saccades element of the Fagan Infantest(24).
They reported increasing maternal TSH concentrations were
associated with a decrease in Percentage Anticipatory
Saccades indicating improved performance amongst the
assessed children at 5 months of age(24). As the NC2 cohort
is larger (n 1535) compared to the NC1 cohort (n 300), and
in tandem with both the high and changing fish consumption
amongst the Seychellois cohort, further investigations into
maternal thyroid function were justified as part of the present
study. Previously conducted studies have reported that there is
a delicate balance regarding thyroid hormone measurements
and cognitive outcomes, with measurement being time-specific
and higher/lower values not necessarily indicative of a simple
better or worse relationship(22,34). It is indeed possible that
minor imbalances in fT3, as indicated in our quintile analysis
(Q3 v. Q4 and Q3 v. Q5), may still be associated with child
neurodevelopment. However, given the lack of association in
our primary model, the small number of participants in high
and low quintiles and the strength of the association found,
further research would be needed to confirm this. Recent
work has also highlighted the importance of understanding
Table 2. Study characteristics of mothers in the SCDS
N Median 25th percentile 75th percentile Max. Min.
Maternal age (years) 1534 25⋅91 21⋅90 31⋅19 46⋅56 14⋅82
Maternal BMI (kg/m2) 1408 26⋅14 21⋅91 30⋅97 49⋅65 14⋅82
Gestational Age (weeks) 1473 39⋅00 38⋅00 40⋅00 41⋅00 26⋅00
Pre-term births 111 – – – – –
Mother’s IQ (KBIT) 1475 30⋅00 25⋅00 35⋅00 −9⋅00 46⋅00
Iodine intake (μg/d) 422 233⋅00 153⋅75 387⋅50 1503 33
Family status 1473 1⋅00 0⋅00 1⋅00 0⋅00 1⋅00
Hollingshead SES 1473 31⋅50 24⋅00 39⋅50 63⋅00 11⋅00
Child age at testing 1472 20⋅00 20⋅00 21⋅00 32⋅00 15⋅00
fTSH (mIU/l) 1329 1⋅24 0⋅90 1⋅68 16⋅80 0⋅25
fT4 (μmol/l) 1330 11⋅60 10⋅50 12⋅70 16⋅80 0⋅03
fT3 (μmol/l) 1330 3⋅73 3⋅38 4⋅06 32⋅80 1⋅24
BMI, body mass index; IQ (KBIT), Intelligence Quotient (Kaufman Brief Intelligence Test); SES, socio-economic status; fTSH, free thyroid-stimulating hormone; μg/d, micrograms
per day; mIU/l, milliunits per litre; fT4, free thyroxine; μmol/l, micromoles per litre; fT3, free triiodothyronine.
Table 3. Associations between maternal concentrations of fT3, fT4 and fTSH with child neurodevelopment outcomesa
fT3 (μmol/l) fT4 (μmol/l) fTSH (mIU/l)
ND test β 95 % Cl P value β 95 % Cl P value β 95 % Cl P value
PDI −0⋅11 (−10⋅726, 7⋅241) 0⋅704 −0⋅049 (−18⋅276, 1⋅560) 0⋅099 −0⋅005 (−2⋅787, 2⋅326) 0⋅860
MDI −0⋅031 (−13⋅946, 4⋅024) 0⋅279 −0⋅032 (−15⋅514, 4⋅430) 0⋅276 0⋅001 (−2⋅519, 2⋅620) 0⋅969
IBQ Surg −0⋅004 (−0⋅662, 0⋅585) 0⋅904 −0⋅041 (−1⋅208, 0⋅197) 0⋅158 0⋅006 (−0⋅161, 0⋅200) 0⋅831
IBG Neg Affect 0⋅003 (−0⋅788, 0⋅875) 0⋅918 0⋅005 (−0⋅857, 1⋅018) 0⋅866 −0⋅031 (−0⋅370, 0⋅112) 0⋅293
IBQ Effortful Control −0⋅026 (−0⋅878, 0⋅336) 0⋅381 −0⋅04 (−1⋅162, 0⋅206) 0⋅171 0⋅026 (−0⋅094, 0⋅258) 0⋅361
CDI Part l Vocab Prod 0⋅008 (−61⋅376, 81⋅406) 0⋅783 −0⋅013 (−100⋅973, 64⋅398) 0⋅664 −0⋅001 (−21⋅535, 20⋅924) 0⋅978
CDI Part l Vocab
Understand
0 (−74⋅428, 75⋅178) 0⋅992 0⋅003 (−81⋅382, 89⋅442) 0⋅926 −0⋅05 (−23⋅975, 19⋅881) 0⋅855
CDI Part l Total Gestures −0⋅013 (−8⋅847, 5⋅299) 0⋅650 −0⋅02 (−10⋅487, 5⋅127) 0⋅501 0⋅015 (−1⋅469, 2⋅540) 0⋅600
ND, neurodevelopment test; mIU/l, milliunits per litre; μmol/l, micromoles per litre; fT4, free thyroxine; fT3, free triiodothyronine; fTSH, free thyroid-stimulating hormone; MDI, Mental
Development Index; PDI, Psychomotor Development Index; IBQ Surg, Infant Behaviour Record-Revised Surgency; IBQ Neg Aff, Infant Behaviour Record-Revised Negative
Affect; IBQ Effor Cont, Infant Behaviour Record-Revised Effortful Control; CDI Part l Voca Prod, MacArthur-Bates Communicative Development Inventories Vocab Produced;
CDI Part l Voca Und, MacArthur-Bates Communicative Development Inventories Vocab Understand; CDI Part l Total Ges, MacArthur-Bates Communicative Development
Inventories Total Gestures.

















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































the natural fluctuation of thyroid hormones throughout preg-
nancy and the potential implications, positive or negative, that
may occur with respect to cognitive outcomes in offspring(35).
Several authors have described the role of maternal T4 sup-
plied to the developing foetus as facilitating growth and devel-
opment of the neuronal cortex, hippocampus, cochlea and
cerebellum(7–9). Future studies should give particular attention
to the importance of measuring thyroid hormones at earlier
stages in gestation such as during the first trimester with
respect to neurodevelopment(35).
Our findings are consistent with those of Threapleton et al.,
who also found no associations between maternal thyroid
function and child cognitive outcomes in a large UK cohort.
This work suggested that the WHO thresholds may be inad-
equate and that alternative functional biomarkers for iodine
status in pregnancy could be identified and thus may provide
additional insight(36). However, the findings of Threapleton
et al.’s work and the overall conclusion drawn from our
research are in contrast with various other studies which
have found associations between maternal thyroid status dur-
ing pregnancy and neurodevelopmental outcomes in offspring.
There are reports that offspring born to mothers with low thy-
roid function in pregnancy had impaired childhood cognitive
function with women classified as thyroid deficient during
pregnancy having offspring with IQ scores of 4–7 points
lower based on the Wechsler Intelligence Scale for Children
(WISC)(37,38). On examining the association of maternal
TSH and T4 with children’s brain volume determined
by MRI at age 10 years, both deficient and excessive con-
centrations throughout pregnancy resulted in smaller brain
volume(39). It is worth noting that these studies were observa-
tional and conducted in different countries (The Netherlands
and USA) which have different dietary patterns, exposure to
iodised salt and population ethnicities.
The present study has several strengths, and it is a large
sample size in a well-characterised population. The measure-
ments of thyroid hormones were robust, and we were able
to account for numerous covariates known to influence neuro-
development. Moreover, we also measured a range of neuro-
developmental outcomes in the offspring.
Like all epidemiology studies, it also has some limitations. We
measured thyroid hormones in the third trimester and were
unable to determine the impact that concentrations of the mater-
nal thyroid hormones might have upon neurodevelopment earl-
ier in pregnancy. However, previous research conducted by both
Lee et al. and Fuse et. al. does indicate that thyroidal changes
throughout pregnancy are minimal in iodine sufficient areas,
such as Japan and Korea as assessed in these studies, and sub-
sequently the Seychelles as analysed in the present study(40,41).
Thus, it is plausible that the 28-week time point used as a testing
point within our Seychellois cohort, who are known to be iodine
sufficient, is potentially not dissimilar to thyroid hormone mea-
surements which could be taken at an earlier time point during
gestation, e.g. first trimester. We did not measure the iodine
composition of Seychellois fish which could have impacted the
accuracy of intake data, nor do we have dietary data for the com-
plete cohort. Additionally, our estimation of iodine intake in the

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Despite the knowledge that either too high or too low
intakes of iodine are associated with poorer childhood neuro-
developmental outcomes in an iodine sufficient population(19),
it is important for future investigations to be conducted within
cohorts with a different dietary pattern than that of the
Seychellois population.
Conclusion
The overall findings of our longitudinal study show that there are
no associations between maternal thyroid function during preg-
nancy and cognitive outcomes at 20 months in the SCDS.
Despite high iodine intakes, which could potentially disrupt mater-
nal thyroid function, there is no evidence of adverse cognitive out-
comes in offspring in this high fish-eating population. Secondary
analysis revealed positive associations between a higher maternal
fT3 concentration and the MDI scores of children when a non-
linear relationship with fT3 was tested by quintile analysis. These
results point to the delicate balance required of thyroid function
during pregnancy for optimal offspring neurodevelopment, results
which warrant further advancement by future studies.
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